| INTRODUCTION
The perceived importance of the HLA-C locus in the human immune system has evolved significantly during the nearly 50 years since it was discovered. 1 Prior to the identification of the KIR family of HLA receptors and their ability to recognize HLA-C in the early 1990s, 2,3 the weak association of HLA-C with β2m, its lower cell surface expression, and the absence of reports describing HLA-C restricted T lymphocytes, had led investigators to propose that HLA-C was a non-functional gene. 4 Although there have been numerous reports of HLA-C restricted T cells since that time, [5] [6] [7] [8] [9] [10] it was the discovery of the killer-cell immunoglobulin-like receptor (KIR) gene family that finally provided a plausible explanation for the appearance of HLA-C in higher primates, and the forces driving its evolution. 11, 12 The hypothesis that HLA-C has evolved to serve as a specialized MHC class I gene and function primarily as a KIR ligand is supported by several lines of evidence: (a) HLA-C is the most recently evolved MHC class I gene, resulting from the duplication and divergence of the HLA-B gene 13 , (b) The emergence and divergence of HLA-C correlates with the expansion of the family of KIR receptors that recognize it, 14 (c) all HLA-C alleles serve as ligands for at least one KIR, whereas only HLA-A and HLA-B alleles that contain the Bw4 epitope are recognized by KIR3DL1. Natural killer (NK) cells are less dependent on the recognition of Bw4, because approximately 50% of the world population possesses Bw4 epitopes in their genome, 15 (d) the level of cell surface expression of HLA-C is less than 10% of HLA-A or HLA-B levels, 16, 17 which is more consistent with a role as a sensor for altered/downregulated class I in infected or transformed cells, rather than presentation of peptides to T cells, 18 (e) the recent identification of an NK-specific upstream HLA-C promoter that is associated with increased HLA-C expression by NK cells, 19 indicates the importance of HLA-C for the development and regulation of NK cells. In this review, I will discuss multiple examples of changes in HLA-C regulatory elements relative to the HLA-A and HLA-B genes, and additional variation between HLA-C This review was invited and edited by the Reviews Editor Katharina Fleischhauer.
alleles in regulatory elements and mRNA splice sites, with respect to the role of HLA-C in controlling NK cell function.
| CORE PROMOTER ELEMENTS
The core promoter region of the HLA-B gene has been extensively investigated, and it has served as a reference gene for the evaluation of variation in regulatory elements and their effect on promoter activity when compared with the HLA-A and HLA-C core promoters. The study of HLA-B transgenic mice showed that only 260 bp 5 0 of the transcription initiation site is sufficient to drive tissue-specific expression of the gene. 20 In vivo foot-printing of the transgenic HLA-B
promoter region showed occupancy of predicted NF-κB (Enhancer A), IRF (ISRE), and CREB (Site α) binding sites. 21 The binding of NF-κB p50/p65 to the Enhancer A site, ISGF2 (IRF-1) and IRF-2 to the ISRE site, and ATF/-CREB to Site α of the HLA-A and HLA-B genes was subsequently shown.
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| Variation in NF-κB regulation
HLA-A contains tandem consensus NF-κB sites, whereas HLA-B has only the 3 0 site (Figure 1 ), and HLA-B was shown to be less responsive to transactivation by NF-κB.
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HLA-C also lacks the 5 0 site, and the 3 0 site contains two non-consensus nucleotides in the majority of alleles ( Figure 1) . Substitution of the 3´HLA-C NF-κB site into an HLA-B reporter vector abrogated tumor necrosis factor (TNF) induction of promoter activity, and the HLA-C site was unable to bind NF-κB proteins, indicating that this element is non-functional in the HLA-C gene. 23 The loss of this site in the HLA-C gene likely reflects an adaptation to its role as a KIR ligand. The induction of higher levels of HLA-C expression at inflammatory sites by TNF or other inducers of NF-κB activity would make cells more resistant to NK killing, possibly allowing neoplastic or virally-infected cells to escape. Furthermore, the loss of the NF-κB site was also associated with a lower basal level of HLA-C transcription relative to HLA-A and HLA-B. 24 A subsequent more detailed study of the differences in expression and promoter sequences of the HLA-A, HLA-B, and HLA-C genes 25 showed that HLA-C mRNA transcripts were present at a much lower level than HLA-A or HLA-B transcripts in primary human endothelial cells, and this correlated with the promoter activity of reporter constructs containing 426 bp of the core promoter region. The disruption of the NF-κB site in the HLA-C gene was shown to be responsible for the decreased promoter activity. However, decreased transcripts and promoter activity were not observed in the HeLa cell line, indicating that additional factors could compensate for the lack of an NF-κB site in these cells.
A study of the level of HLA protein expression in peripheral blood lymphocytes showed that HLA-A and HLA-B are expressed on the cell surface at levels that are 13 to18 times higher than that of HLA-C. Determination of total cellular protein levels by mass spectrometry indicated only a 4 to 5-fold difference, 17 in agreement with previous reports that HLA-C is inefficiently exported to the cell surface. 26 These observations are consistent with a primary role of HLA-C in NK cell regulation rather than antigen presentation. 
| The interferon-stimulated response element
The interferon-stimulated response element (ISRE) of HLA-A has been shown to be less responsive to interferon (IFN)-γ induction than the HLA-B or HLA-C element. 22, 27 This was initially suggested to be the result of a difference in binding of IRF to the HLA-A element. 28 However, similar binding of IRF-1 to the HLA-A and HLA-B/HLA-C elements has been reported, 27 and substitution of the HLA-A IRF element into the HLA-B promoter did not affect IFN responsiveness. 25 A comparison of the 3 0 -flanking sequence of the ISRE regions of HLA-A and HLA-B/HLA-C, shows a potential STATbinding site (TTCTCCCAA) that is related to the GAS site (TTCCCCTAA) located adjacent to an IRF site in the human TAP1 promoter, 29 and this element is disrupted in the HLA-A gene (CTCTCCCAA) because of a 3 bp insertion ( Figure 1 ). Re-examination of the electrophoretic mobility shift assays (EMSAs) performed by Girdlestone et al. 22 that used probes encompassing both the IRF and putative STAT sites, shows the presence of additional higher molecular weight complexes consistent with STAT binding that are generated by an HLA-B probe, but not by an HLA-A probe.
The putative STAT-binding site is conserved in all HLA-B alleles and most HLA-C alleles (30; Figure 1 ). However, HLA-C transcription is only weakly induced by IFN and/or TNF, 24 because of the requirement of NF-κB for strong IFNmediated induction. The decreased responsiveness could result in HLA-C being more sensitive to down-regulation by viruses, consistent with HLA-C being the primary KIR ligand used to detect missing self. It is interesting to note that three HLA-C alleles (HLA-C*05/*08/*17) have acquired single nucleotide polymorphism (SNPs) that could potentially alter STAT binding (30; Figure 1 ), suggesting selection for diminished IFN responsiveness in these alleles. In addition, the HLA-C*07 allele has a 3 bp deletion that does not disrupt either the IRF or the STAT site, but results in an overlap of these sites that may prevent both factors from binding to this region at the same time. There is a dinucleotide polymorphism on the 5 0 side of the IRF-binding element in a subset of HLA-B alleles that generates a USF-binding site, but this variation only affects basal promoter activity and not IFN-induction. 27 Furthermore, the USF-binding site is equally distributed among KIR-binding (Bw4) and nonbinding (Bw6) alleles, 30 suggesting that this variation is not associated with modulation of the recognition of HLA-B by KIR3DL1.
| The enhanceosome
The core promoter of most class I genes (HLA-A, HLA-B, HLA-C, HLA-E, and HLA-F) is driven by an enhanceosome that cooperatively binds RFX (site X1), CREB/ATF (site α/X2), and NF-Y (Enhancer B), providing a platform for the recruitment of CIITA, as shown for the class II genes.
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HLA-G transcription is not CIITA-dependent, consistent with its specific expression in trophoblasts, which do not express CIITA. A comparison of the enhanceosome sequence between the HLA-A, HLA-B, and HLA-C genes showed an SNP in the X2/α element of the HLA-A gene that was predicted to affect CREB binding, but this SNP did not affect the CIITA transactivation of HLA-A or HLA-B promoters containing this SNP. 25 An examination of the enhancer region across all genes and alleles shows complete conservation of the NF-Y binding site, and only one HLA-A -specific change in the CREB site as discussed above. However, there is a single nucleotide change in the HLA-C gene that disrupts the RFX-binding site, possibly affecting the tissue specificity of the enhancer (Figure 1) . Interestingly, the HLA-C gene has potential ETS and C/EBP binding sites that overlap with the predicted RFX-binding site of the HLA-A and HLA-B genes. This difference may be associated with the ability of HLA-C, but not HLA-A or HLA-B, to be expressed by trophoblasts, as described in section 3.
| Tuning of core promoter activity in HLA-C alleles
Cell surface expression of HLA-C varies in an allele-specific manner, and high cell surface expression of HLA-C has been associated with reduced viral loads and increased CTL responses in HIV infection. 32 ; and a recent study demonstrating that the HLA-C*07 allele is poorly expressed at the cell surface because of a more restrictive peptide-binding pocket rather than differences in transcription. 38 There is however some precedent for considering allelic differences in core promoter elements with regard to HLA-C expression patterns. Allelic differences in the NF-κB and IRF-1 binding sites were shown to affect both constitutive and cytokine-induced promoter activity when studied in reporter assays. 39 A comparison of the HLA-C*03, HLA-C*06, and HLA-C*07 alleles indicated that an SNP restoring the consensus binding sequence in one half of the NF-κB palindrome in HLA-C*07 was associated with higher basal promoter activity and greater TNF induction in reporter assays and in primary keratinocytes. The IRF-1 binding site of HLA-C*07 is unique among HLA-C alleles, because it possesses a 3-bp deletion that does not disrupt the IRFbinding consensus, but changes the spacing between the IRF site and a putative STAT-binding site located on the 3 0 side.
Hundhausen et al. 39 observed increased IFN responsiveness of the HLA-C*07 allele in reporter assays, but this was not seen in IFN-stimulated primary keratinocytes. The HLA-C*03 core promoter had the lowest basal promoter activity, consistent with the observation that it has the lowest level of mRNA expression. 17, 40 Interestingly, HLA-C*03 contains a polymorphism that disrupts the TATA element, and this alteration is also present in the HLA-C*17 allele (Figure 1 ).
| TROPHOBLAST-SPECIFIC EXPRESSION OF HLA-C
The recognition of HLA-C on fetal trophoblasts by maternal decidual NK cells has been reported to have an effect on the success of pregnancy. 41, 42 Unlike most tissues, which express HLA-A, HLA-B, HLA-C, and HLA-E, extravillous trophoblasts lack expression of HLA-A and HLA-B, but express HLA-C together with the non-classical MHC class I HLA-E and HLA-G molecules. [43] [44] [45] Trophoblasts lack expression of the CIITA molecule, 46 which recruits the CBP/p300 complex required for chromatin remodeling and gene activation, providing an explanation for the lack of MHC class II expression by trophoblasts. Therefore, HLA genes would require a CIITA-independent mechanism to be activated in trophoblasts. Numerous transcription factors are able to directly recruit CBP/p300, including C/EBPβ, 47 which was found to bind a distal enhancer element in the HLA-G gene. 48 The ability of the HLA-C gene to be transcriptionally active in trophoblast cells that are incapable of expressing the neighboring HLA-B gene, suggests that there may be changes in the core promoter that endow trophoblast specificity to the HLA-C promoter rather than a distal enhancer element. A recent study has shown that a trophoblast-specific promoter is embedded within the HLA-C core promoter region. 49 A distinct transcription initiation region that is 32 nucleotides upstream of the common start site associated with the HLA-A, HLA-B, and HLA-C core promoters is used in trophoblasts. An appropriately spaced array of additional core promoter elements (TATA box, CAAT box) are located upstream of the trophoblast start site, and these are only present in the HLA-C gene. Furthermore, an additional putative CREB-binding site is present in the HLA-C gene 23 bp upstream of the common CREB (X2) site. This upstream site has a single non-consensus nucleotide; however, it is identical to the CREB site of the HLA-A gene. Although both of these CREB sites only differed from the consensus by a single nucleotide, they showed very weak CREB-binding ability. 49 Remarkably, the upstream CREB site in the HLA-A gene bound CREB very strongly, even though it differed from the consensus at two 3 0 nucleotides. Promoter assays showed that the HLA-C core promoter was significantly more active than the HLA-A or HLA-B promoters when tested in trophoblast cell lines. The trophoblast specificity of HLA-C was mapped to the enhanceosome region, and a single nucleotide change that disrupts the RFX-binding site present in the HLA-A and HLA-B genes, was sufficient to confer trophoblast specificity. An overlapping ETS-binding site in the HLA-C gene was shown to bind ELF1 and ELF3. 49 ELF3 is upregulated by invading trophoblasts, 50 suggesting that it may be required for the activation of the HLA-C gene in these cells. ELF3 has been shown to interact with p300 and CBP, 51 thus, providing a CIITA-independent mechanism to recruit the CBP/p300 transcriptional coactivators required for chromatin remodeling and activation of the HLA-C gene in trophoblasts that lack CIITA expression.
| UPSTREAM ELEMENTS
4.1 | The −800 enhancer region A study of SNPs associated with the level of HLA-C mRNA expression identified an SNP in a predicted Oct-binding site 800 bp upstream of the transcription start site as being highly associated with differences in HLA-C expression between alleles. 37 The presence of an A nucleotide in place of a G at this position was associated with higher Oct-1 binding and transcriptional activity. This association was confirmed in a genome-wide expression quantitative trait analysis of HLA-C mRNA levels determined by qPCR of peripheral blood mononuclear cell RNA from 273 individuals. 37, 40 Interestingly, the group of HLA-C alleles that have the highest level of expression (HLA-C*01, *04, *06, *12, and *14), all possess the A residue associated with higher promoter activity. 30, 32 Furthermore, a second SNP located 20 bp upstream of the Oct-1 site was also significantly associated with HLA-C transcript levels, and this SNP is located within a putative NFAT-AP1 binding site, 52 suggesting the presence of an enhancer element in this region. A comparison of this region between HLA-A, HLA-B, and HLA-C shows the presence of significant gene-specific and allelespecific SNPs (Figure 2A) . The three transcription factorbinding regions found in the HLA-B and HLA-C genes are not present in the HLA-A gene. The NFAT site has a single non-consensus nucleotide in all HLA-B alleles, as well as several HLA-C alleles: however, it is disrupted by a 2 bp deletion in the HLA-A gene. An adjacent SP1-binding site is only present in the HLA-B gene. NFAT has been shown to associate with SP1, 53 and a tandem NFAT-SP1 site is present within a human IL3 enhancer active in T cells and mast cells. 54 Therefore, it appears that this enhancer evolved in the HLA-B gene, and its activity was further refined in the HLA-C gene. An analysis of the tissue specificity of the HLA-B and HLA-C -800 enhancer elements is necessary in order to fully understand the evolutionary forces driving their emergence.
| The distal NK-specific promoter of HLA-C
The recent discovery of an NK-specific promoter in the HLA-C gene 19 provides a compelling example of the molecular evolution of this gene for a role in controlling NK cell function. Remarkably, the homologous region of the HLA-A gene has what appears to be a macrophage-specific promoter, and there is no conservation of predicted transcription factor-binding sites between these genes. In contrast, there is nearly complete conservation of transcription factorbinding sites between the HLA-B and HLA-C genes, with the exception of an Ets-binding site that was shown to be required for increased HLA-C expression by NK cells ( Figure 2B ). This suggests that a tissue-specific promoter/ enhancer in the HLA-A gene changed to a different, as yet unknown specificity in the HLA-B gene, and this further developed into an NK-specific promoter in the HLA-C gene. There are only two examples of HLA-B distal transcripts in Genbank, one from a breast tumor tissue sample (DB003310) and another from heart tissue (DA561140), indicating that the HLA-B element is either a very weak promoter, or it is active only in a very small subset of cells. The low level of HLA-B distal transcripts observed in purified NK cells from several individuals 19 suggests that a contaminating lymphocyte population could be the source of the HLA-B transcripts. It will be important to conduct a more thorough examination of the cell-type specificity of the HLA-A and HLA-B distal promoters and the effect of their distal transcripts on protein expression levels.
| Fine-tuning of HLA-C expression by alternative splicing of distal HLA-C transcripts
The structure of the 5 0 UTR of distal HLA-C transcripts is highly variable because of the presence of three untranslated exons that can vary in size because of the use of alternative splice donor and acceptor sites. 19 Seven different first exons (−1a 1-7 ), six-second exons (−1b [1] [2] [3] [4] [5] [6] ), and four-third exons (−1c [1] [2] [3] [4] ) have been observed, along with seven different isoforms of the first coding exon containing from 8 to 630 bp of 5 0 non-coding nucleotides. Furthermore, there are three non-coding exons that are only found in specific alleles. The HLA-C*06 and HLA-C*12 alleles have a larger second exon (−1b 2 ) because of an alternative splice donor found only in these alleles. Alternative exons −1b 3 and −1b 4 are only found in HLA-C*01 and HLA-C*04 alleles because of an additional splice donor site found only in these alleles. The differences in size and sequence content of the -1b exon between alleles may have an impact on the translatability of HLA-C mRNAs, providing an additional mechanism to tune expression levels. An inverse correlation between the size of the 5 0 UTR and the translatability of the HLA-C mRNA has been observed. 19 However, the effect of allele-specific exons on HLA-C expression has yet to be determined. It will also be of interest to determine if the level of NK cell HLA-C expression of specific alleles is inversely correlated with the affinity of a given allele for its cognate KIR.
| CONCLUSION
It appears that the HLA-C gene has undergone numerous changes affecting both gene transcription and protein structure that have resulted in a lower level of cell surface expression and reduced cytokine responsiveness relative to the HLA-A and HLA-B genes. Figure 3 summarizes the changes in promoter elements observed between the HLA-A, HLA-B, and HLA-C genes. A predicted enhancer element at −800 is present in the HLA-B and HLA-C genes, but not in the HLA-A ( Figure 3A) . The predicted NFAT-associated transcription factor has changed from SP1 in the HLA-B gene to AP1 in the HLA-C gene, suggesting that a change in the response to cytokine stimulation or tissue specificity of the enhancer has occurred. The upstream promoter region has undergone a dramatic change from HLA-A to HLA-B, with numerous novel predicted transcription factor-binding sites appearing, and elimination of the binding sites associated with macrophage-specific transcription. A more subtle change has occurred between HLA-B and HLA-C, with the addition of an ETS-binding site, creating a tandem SP1-ETS site that has been associated with NK-specific transcription. 19 The core promoter region of HLA-C has undergone changes to make it less inducible, and it appears to have gained additional transcription factor-binding sites to enable transcription in fetal trophoblasts ( Figure 3B ). There is a progressive loss of NF-κB binding sites from two in HLA-A, to one in HLA-B, and none in HLA-C, suggesting a selection against inducible expression as the HLA genes adapt to a role as a KIR ligand. The expression of HLA-C but not HLA-A or HLA-B by trophoblasts should be associated with the presence of an HLA-C tissue-specific enhancer, as observed for the HLA-G gene. 48 It appears that the enhanceosome region of the HLA-C core promoter has exchanged the RFXbinding site for an expanded ETS-binding site in order to allow trophoblast expression.
(A) (B) The regulatory elements of the HLA-A, HLA-B, and HLA-C genes provide significant insight into the evolutionary history of these genes and the forces driving their specialization. The recent identification of novel enhancer and promoter regions in the HLA-C gene and the comparison with highly-related elements in HLA-B vs distinct HLA-A elements, promises to provide additional information with regard to the evolution of these genes for unique roles in the regulation of the immune system.
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